Certainly, triplication (i.e., the presence of three copies) of chromosome 21 in Down syndrome increases APP gene abundance and also the occurrence of clinical amyloidosis and dementia based on the classical amyloid/tau phosphorylation pathway [7]. This evidence concerns the gene APP and dementia.